Cost-Effective Analysis of Generic versus Branded Oral Hypoglycaemic Agents in Patients with Type 2 Diabetes Mellitus- A Prospective Observational Study
Journal Title: Scholars Journal of Applied Medical Sciences - Year 2018, Vol 6, Issue 10
Abstract
Diabetes is a disproportionately expensive disease which requires a lifelong medical treatment. Many patients cut back on medication use because of cost pressures. It is claimed that the cost of generic medicines having the same quality as that of branded medicines is much cheaper than their branded equivalent. The present study was conducted to compare hypoglycemic effect and cost of generic oral hypoglycemic agents or oral antidiabetic agents (OADs) with their branded counterparts in this part of country. Patients, who fulfilled the selection criteria, were divided into 3(three) categories with two subgroups in each category as follows: Category 1: Patients received generic or branded metformin-500mg/day. Category 2: Patients received generic or branded metformin-1000mg/day. Category 3: Patients received generic or branded (Glimeperide1mg + metformin 500mg)/day. Body weight, blood pressure, fasting and postprandial glucose level were recorded at initial visit and at the end of 30 days. The cost of 30days therapy of branded OADs and their generic versions were recorded. Patients were monitored continuously throughout the study for any adverse event. In this study 162 patients were enrolled, out of all patients 99 were male and 63 were female. The reduction of fasting and postprandial glucose level by generic metformin 500mg/day, generic metformin 1000mg/day and generic (glimepiride 1mg+metformin 500mg)/day was comparable with their branded counterparts. There was no statistical difference between generic drug and branded counterparts in relation to weight and blood pressure change. The cost of generic OADs in this study was much cheaper (3.79 to 11 times) than their branded counterparts. There was no significant difference of AEs among the groups. The generic metformin and generic glimepiride-metformin combination are equally effective and safe as compared to their branded counterparts.
Authors and Affiliations
Dr. Lakshman Das, Dr. Mukut Roy, Miss Vaishali Majumder
Keywords
Related Articles
- EP ID EP478623
- DOI -
- Views 67
- Downloads 0
Meckel’s Diverticulum, Presentation and its Management at Basaveshwara Teaching and General Hospital
Meckel’s Diverticulum has an estimated prevalence of 1.2% of the population. Most cases are asymptomatic and the diagnosis is often made intra-operatively. Surgical resection is the treatment of choice in patients with s...
Hepatic Failure Resulting from Neonatal Thyrotoxicosis
The objective was we report a case of jaundice, fulminant hepatic failure and pulmonary hypertension in premature baby caused by neonatal thyrotoxicosis. The Methods were We describe the clinical and laboratory findings...
Management of Pseudo Class III malocclusion with Reverse Twin Block
Abstract: Class III malocclusion has been an enigma for Pediatric dentists and Orthodontists. Pseudo class III malocclusion are often accompanied with anterior cross bite, which if left untreated leads to accelerated occ...
Plaques Scores and Gingival Health Status between 5 To 20 Years Old Orphans and Parented Children
Abstract: The study was conducted to assess plaque and gingival scores among orphans and parented children. This study was planned in an Orphanage school and a Private school. A total of 84 subjects were examined includi...
A comparative study between transdermal patches of Buprenorphine andFentanyl for postoperative pain relief following orthopaedic surgery underregional anaesthesia
Abstract: Transdermal buprenorphine and fentanyl is commonly used for chronic pain management. Our aim was to evaluate the efficacy of transdermal buprenorphine and fentanyl patch in postoperative acute pain management.A...